CSBTF News Today: Stay Updated with the Latest Kuros Biosciences AG News in Real Time
Find CSBTF news now at Meyka AI. Stay informed with the latest Kuros Biosciences AG stocks updates, including price news, market analysis, and expert insights.
Kuros Biosciences AG Surges 7.66% on Biotech Recovery Momentum
KURN.SW stock jumps 7.66% to CHF22.20 on SIX. Biotech recovery drives gains as orthobiologics pipeline advances.
Genocea Biosciences Stock Collapses 97% as Bankruptcy Restructuring Continues
GNCA stock plummets 97.44% to $0.0001 after Chapter 11 bankruptcy filing. Biotech firm restructures cancer immunotherapy pipeline.
AURA Director Holles Acquires 2.17M Stock Options on May 20, 2026
Aura Biosciences director Natalie Holles acquired 2.17M stock options worth $16M on May 19, 2026. Insider buying signal analyzed.
Willow Biosciences Stock Plummets 84.8% in One Day on TSX
WLLW.TO stock crashes 84.8% in single trading session. Biotech firm faces severe valuation pressure amid ongoing losses.
Idorsia Ltd (IDIA.SW) Surges 7.2% on Strong Biotech Pipeline Momentum
IDIA.SW stock rises to CHF4.58. Biotech firm advances clinical pipeline with partnerships in CNS, cardiovascular, and orphan disease treatments.
Kuros Biosciences AG Surges 8.95% on Strong Trading Volume
KURN.SW stock jumps 8.95% to CHF 20.7 on SIX with 355,006 shares traded, driven by biotech investor interest.
Genocea Biosciences Stock Collapses 97% as GNCA Faces Bankruptcy Aftermath
GNCA stock plummets 97.44% to $0.0001 following Chapter 11 bankruptcy filing. Genocea Biosciences faces severe delisting risk on NASDAQ.
IDIA.SW stock surges 6.68% on May 12, 2026 as biotech gains momentum
IDIA.SW stock rises 6.68% to CHF 4.15 on May 12, 2026. Idorsia Ltd biotech stock shows strong intraday momentum on SIX exchange.
MBX Biosciences CMO Acquires 55K Stock Options on May 8, 2026
MBX CMO Azoulay Salomon acquired 55,000 stock options valued at $575,300 on May 8, 2026, per SEC filing insider transaction disclosure.